We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+5.78%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$202M
AUM Growth
-$20.4M
(-9.2%)
Cap. Flow
-$72M
Cap. Flow
% of AUM
-35.68%
Top 10 Holdings %
Top 10 Hldgs %
32.61%
Holding
161
New
27
Increased
32
Reduced
22
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Everspin Technologies
MRAM
|
+$3.23M |
| 2 |
Mirum Pharmaceuticals
MIRM
|
+$1.21M |
| 3 |
Lantronix
LTRX
|
+$1.2M |
| 4 |
SCYNEXIS
SCYX
|
+$920K |
| 5 |
Context Therapeutics
CNTX
|
+$872K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMKR
Emcore Corp
EMKR
|
+$5.2M |
| 2 |
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
|
+$3.83M |
| 3 |
ADMS
Adamas Pharmaceuticals
ADMS
|
+$3.1M |
| 4 |
OIIM
02Micro International
OIIM
|
+$2.06M |
| 5 |
Aviat Networks
AVNW
|
+$1.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 11.1% |
| 3 | Financials | 3.75% |
| 4 | Consumer Discretionary | 3.07% |
| 5 | Real Estate | 1.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Lantronix
LTRX
$240M
| $1.24M | 0.61% |
+158,128
| New | +$1.2M |
|
|
27
Mirum Pharmaceuticals
MIRM
$6.46B
| $1.24M | 0.61% |
+77,515
| New | +$1.21M |
|
28
Allot
ALLT
$372M
| $1.22M | 0.6% |
102,375
+20,668
| +25% | +$271K |
|
29
Booking.com
BKNG
$149B
| $1.2M | 0.59% |
12,500
+125
| +1% | +$11.9K |
|
30
Bank of America
BAC
$435B
| $1.15M | 0.57% |
25,842
| – | – |
|
|
OIIM
31
DELISTED
02Micro International
OIIM
| $1.11M | 0.55% |
245,608
-364,129
| -60% | -$2.06M |
|
32
Digital Turbine
APPS
$975M
| $1.01M | 0.5% |
16,524
-3,937
| -19% | -$268K |
|
33
Microchip Technology
MCHP
$40.3B
| $961K | 0.48% |
11,038
+678
| +7% | +$54.8K |
|
|
WTT
34
DELISTED
Wireless Telecom Group, Inc.
WTT
| $956K | 0.47% |
434,407
| – | – |
|
35
Myomo
MYO
$39M
| $949K | 0.47% |
138,686
+59,396
| +75% | +$566K |
|
36
RF Industries
RFIL
$134M
| $933K | 0.46% |
116,684
| – | – |
|
|
ZUO
37
DELISTED
Zuora, Inc.
ZUO
| $884K | 0.44% |
47,313
-7,132
| -13% | -$143K |
|
38
Simon Property Group
SPG
$74.4B
| $847K | 0.42% |
5,300
-300
| -5% | -$45.8K |
|
|
MDNA
39
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
| $837K | 0.41% |
513,089
+298,059
| +139% | +$618K |
|
|
CDR
40
DELISTED
Cedar Realty Trust, Inc
CDR
| $800K | 0.4% |
31,855
+2,400
| +8% | +$54.2K |
|
41
X4 Pharmaceuticals
XFOR
$375M
| $780K | 0.39% |
11,350
-1,533
| -12% | -$194K |
|
|
HTGM
42
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $776K | 0.38% |
11,928
| – | – |
|
43
Lightpath Technologies
LPTH
$651M
| $767K | 0.38% |
+314,407
| New | +$648K |
|
44
BK Technologies
BKTI
$300M
| $751K | 0.37% |
62,337
| – | – |
|
45
TransCode Therapeutics
RNAZ
$4.83M
| – | – |
0
| – | – |
|
46
NVE Corp
NVEC
$562M
| $744K | 0.37% |
10,893
+1,365
| +14% | +$93.5K |
|
|
DCBO
47
Docebo
DCBO
$525M
| $737K | 0.37% |
+10,945
| New | +$787K |
|
48
Pixelworks
PXLW
$38.2M
| $690K | 0.34% |
13,075
+1,610
| +14% | +$90.8K |
|
|
FARO
49
DELISTED
Faro Technologies
FARO
| $668K | 0.33% |
9,545
+818
| +9% | +$58.8K |
|
|
NBSE
50
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $644K | 0.32% |
+11,463
| New | +$770K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Worth Venture Partners held 161 positions worth $202M, down 9.2% from $222M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Worth Venture Partners withdrew a net $72M in Q4 2021, closing 30 positions and reducing 22 holdings. Its most notable exit was Galera Therapeutics, Inc. Common Stock, an estimated $3.83M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in Everspin Technologies worth $4.03M.
- Worth Venture Partners's largest Q4 2021 buy was Everspin Technologies: 356,722 shares worth $4.03M.
- Worth Venture Partners added most to SCYNEXIS in Q4 2021, an estimated $920K increase.
- Worth Venture Partners's biggest Q4 2021 reduction was Emcore Corp, cutting an estimated $5.2M.
- Worth Venture Partners fully exited Galera Therapeutics, Inc. Common Stock in Q4 2021, selling an estimated $3.83M.
- Worth Venture Partners's ten largest holdings make up 33% of its $202M portfolio in Q4 2021.
- Worth Venture Partners opened 27 new positions and closed 30 in Q4 2021.
- Worth Venture Partners's portfolio value fell 9.2% quarter-over-quarter to $202M.
Based on Worth Venture Partners's 13F filing for Q4 2021, filed 14 Feb 2022.